193 related articles for article (PubMed ID: 21783272)
1. Mice expressing human CR1/CD35 have an enhanced humoral immune response to T-dependent antigens but fail to correct the effect of premature human CR2 expression.
Pappworth IY; Hayes C; Dimmick J; Morgan BP; Holers VM; Marchbank KJ
Immunobiology; 2012 Feb; 217(2):147-57. PubMed ID: 21783272
[TBL] [Abstract][Full Text] [Related]
2. Human complement receptor type 2 (CR2/CD21) transgenic mice provide an in vivo model to study immunoregulatory effects of receptor antagonists.
Kulik L; Chen K; Huber BT; Holers VM
Mol Immunol; 2011 Mar; 48(6-7):883-94. PubMed ID: 21269698
[TBL] [Abstract][Full Text] [Related]
3. Defective B cell ontogeny and humoral immune response in mice prematurely expressing human complement receptor 2 (CR2, CD21) is similar to that seen in aging wild type mice.
Twohig JP; Pappworth IY; Sivasankar B; Kulik L; Bull M; Holers VM; Wang EC; Marchbank KJ
Mol Immunol; 2009 Jun; 46(10):2002-13. PubMed ID: 19359041
[TBL] [Abstract][Full Text] [Related]
4. A new mouse anti-mouse complement receptor type 2 and 1 (CR2/CR1) monoclonal antibody as a tool to study receptor involvement in chronic models of immune responses and disease.
Kulik L; Hewitt FB; Willis VC; Rodriguez R; Tomlinson S; Holers VM
Mol Immunol; 2015 Feb; 63(2):479-88. PubMed ID: 25457881
[TBL] [Abstract][Full Text] [Related]
5. B cells from mice prematurely expressing human complement receptor type 2 are unresponsive to T-dependent antigens.
Birrell L; Kulik L; Morgan BP; Holers VM; Marchbank KJ
J Immunol; 2005 Jun; 174(11):6974-82. PubMed ID: 15905540
[TBL] [Abstract][Full Text] [Related]
6. Mouse complement receptors type 1 (CR1;CD35) and type 2 (CR2;CD21): expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice.
Takahashi K; Kozono Y; Waldschmidt TJ; Berthiaume D; Quigg RJ; Baron A; Holers VM
J Immunol; 1997 Aug; 159(3):1557-69. PubMed ID: 9233655
[TBL] [Abstract][Full Text] [Related]
7. Optimal germinal center B cell activation and T-dependent antibody responses require expression of the mouse complement receptor Cr1.
Donius LR; Handy JM; Weis JJ; Weis JH
J Immunol; 2013 Jul; 191(1):434-47. PubMed ID: 23733878
[TBL] [Abstract][Full Text] [Related]
8. Expression of human complement receptor 2 (CR2, CD21) in Cr2-/- mice restores humoral immune function.
Marchbank KJ; Watson CC; Ritsema DF; Holers VM
J Immunol; 2000 Sep; 165(5):2354-61. PubMed ID: 10946257
[TBL] [Abstract][Full Text] [Related]
9. Intrinsic B cell hypo-responsiveness in mice prematurely expressing human CR2/CD21 during B cell development.
Kulik L; Marchbank KJ; Lyubchenko T; Kuhn KA; Liubchenko GA; Haluszczak C; Gipson MG; Boackle SA; Holers VM
Eur J Immunol; 2007 Mar; 37(3):623-33. PubMed ID: 17301948
[TBL] [Abstract][Full Text] [Related]
10. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2.
Molina H; Holers VM; Li B; Fung Y; Mariathasan S; Goellner J; Strauss-Schoenberger J; Karr RW; Chaplin DD
Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3357-61. PubMed ID: 8622941
[TBL] [Abstract][Full Text] [Related]
11. Increased survival in B-cell-deficient mice during experimental cerebral malaria suggests a role for circulating immune complexes.
de Oliveira RB; Wang JP; Ram S; Gazzinelli RT; Finberg RW; Golenbock DT
mBio; 2014 Mar; 5(2):e00949-14. PubMed ID: 24643866
[TBL] [Abstract][Full Text] [Related]
12. Generation of a novel Cr2 gene allele by homologous recombination that abrogates production of Cr2 but is sufficient for expression of Cr1.
Donius LR; Orlando CM; Weis JJ; Weis JH
Immunobiology; 2014 Jan; 219(1):53-63. PubMed ID: 24012440
[TBL] [Abstract][Full Text] [Related]
13. Complement receptor type 1 (CR1, CD35) is a potent inhibitor of B-cell functions in rheumatoid arthritis patients.
Kremlitzka M; Polgár A; Fülöp L; Kiss E; Poór G; Erdei A
Int Immunol; 2013 Jan; 25(1):25-33. PubMed ID: 22962438
[TBL] [Abstract][Full Text] [Related]
14. Complement receptors regulate lipopolysaccharide-induced T-cell stimulation.
Kaya Z; Tretter T; Schlichting J; Leuschner F; Afanasyeva M; Katus HA; Rose NR
Immunology; 2005 Apr; 114(4):493-8. PubMed ID: 15804286
[TBL] [Abstract][Full Text] [Related]
15. Increased B cell deletion and significantly reduced auto-antibody titre due to premature expression of human complement receptor 2 (CR2, CD21).
Pappworth IY; Kulik L; Haluszczak C; Reuter JW; Holers VM; Marchbank KJ
Mol Immunol; 2009 Mar; 46(6):1042-9. PubMed ID: 19187965
[TBL] [Abstract][Full Text] [Related]
16. Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response.
Fang Y; Xu C; Fu YX; Holers VM; Molina H
J Immunol; 1998 Jun; 160(11):5273-9. PubMed ID: 9605124
[TBL] [Abstract][Full Text] [Related]
17. Antibody response to a T-dependent antigen requires B cell expression of complement receptors.
Croix DA; Ahearn JM; Rosengard AM; Han S; Kelsoe G; Ma M; Carroll MC
J Exp Med; 1996 Apr; 183(4):1857-64. PubMed ID: 8666942
[TBL] [Abstract][Full Text] [Related]
18. Dependence of germinal center B cells on expression of CD21/CD35 for survival.
Fischer MB; Goerg S; Shen L; Prodeus AP; Goodnow CC; Kelsoe G; Carroll MC
Science; 1998 Apr; 280(5363):582-5. PubMed ID: 9554848
[TBL] [Abstract][Full Text] [Related]
19. Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells.
Kozono Y; Abe R; Kozono H; Kelly RG; Azuma T; Holers VM
J Immunol; 1998 Feb; 160(4):1565-72. PubMed ID: 9469411
[TBL] [Abstract][Full Text] [Related]
20. Expression of human complement receptor type 2 (CD21) in mice during early B cell development results in a reduction in mature B cells and hypogammaglobulinemia.
Marchbank KJ; Kulik L; Gipson MG; Morgan BP; Holers VM
J Immunol; 2002 Oct; 169(7):3526-35. PubMed ID: 12244142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
